Jeffrey D. Isaacson
- Infectious Diseases top 5%
- Pulmonary and Respiratory Medicine top 10%
- Virology top 2%
- Oncology top 10%
- Molecular Biology
- Co-authors
- Michael A. CarducciMartin KingRichard A. RodeEugene SunDale J. KempfBarry BernsteinDarryl J. SleepDavid P. Dearnaley
- Topics
- Prostate Cancer Treatment and Research (12 papers)Bone health and treatments (8 papers)Radiopharmaceutical Chemistry and Applications (7 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Jeffrey D. Isaacson
29 papers receiving 953 citations
Peers
Comparison fields: 5 of 62
- Infectious Diseases 407
- Pulmonary and Respiratory Medicine 388
- Virology 343
- Oncology 286
- Molecular Biology 169
Countries citing papers authored by Jeffrey D. Isaacson
This map shows the geographic impact of Jeffrey D. Isaacson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Isaacson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Isaacson more than expected).
Fields of papers citing papers by Jeffrey D. Isaacson
This network shows the impact of papers produced by Jeffrey D. Isaacson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Isaacson. The network helps show where Jeffrey D. Isaacson may publish in the future.
Co-authorship network of co-authors of Jeffrey D. Isaacson
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Isaacson. A scholar is included among the top collaborators of Jeffrey D. Isaacson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Isaacson. Jeffrey D. Isaacson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | 4 | |
| 4 | 2 | |
| 5 | 8 | |
| 6 | 18 | |
| 7 | 4 | |
| 8 | 236 | |
| 9 | 3 | |
| 10 | 38 | |
| 11 | 1 | |
| 12 | 3 | |
| 13 | 2 | |
| 14 | 1 | |
| 15 | 43 | |
| 16 | 2 | |
| 17 | 1 | |
| 18 | Phase I dose-escalation study of the safety and pharmacokinetics of atrasentan: an endothelin receptor antagonist for refractory prostate cancer. | 41 |
| 19 | 125 | |
| 20 | 31 |
About Jeffrey D. Isaacson
Jeffrey D. Isaacson is a scholar working on Virology, Oncology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 993 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (12 papers), Bone health and treatments (8 papers) and Radiopharmaceutical Chemistry and Applications (7 papers). The work is most often cited by research in Virology (343 citations), Infectious Diseases (407 citations) and Pulmonary and Respiratory Medicine (388 citations). Jeffrey D. Isaacson has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Michael A. Carducci, Martin King, Richard A. Rode, Eugene Sun, Dale J. Kempf, Barry Bernstein, Darryl J. Sleep, David P. Dearnaley, Joel B. Nelson and Claude C. Schulman. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Journal of Virology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.